Earnings Scheduled For April 10, 2024
Companies Reporting Before The Bell
• Delta Air Lines (NYSE:DAL) is projected to report quarterly earnings at $0.35 per share on revenue of $12.55 billion.
Theratechnologies Earnings Preview
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Wednesday, 2024-02-21. Here’s what investors need…
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Gainers
Appreciate Holdings, Inc. (NASDAQ: SFR) shares surged 103.8% to $0.2460 in pre-market trading after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding delisting.
Theratechnologies Announces Pricing Of $25M Public Offering Of Common Shares And Concurrent Private Placement
Theratechnologies Inc. ("Theratechnologies" or the "Company") (NASDAQ:THTX, TSX:TH), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it has
Theratechnologies Announces Proposed Public Offering Of Common Shares And Concurrent Private Placement; No Size Or Amount Disclosed
Theratechnologies Inc. ("Theratechnologies" or the "Company") (NASDAQ:THTX, TSX:TH), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the launch of a
Earnings Scheduled For September 26, 2023
Companies Reporting Before The Bell
• Ferguson (NYSE:FERG) is estimated to report quarterly earnings at $2.46 per share on revenue of $7.60 billion.
Earnings Outlook For Theratechnologies
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Tuesday, 2023-09-26. Here’s what investors need…
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.